Allen Bramian
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Allen Bramian has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Kei M. Igarashi
Department of Anatomy and Neurobiology, School of Medicine, University of California, Irvine, CA 92697, USA
2 shared publications Christian J Leonardo
Stony Brook University
1 shared publicationEdward D Wang
Stony Brook University
1 shared publication- Heechul Jun
Department of Anatomy and Neurobiology, School of Medicine, University of California, Irvine, USA
1 shared publication - Heechul Jun
Department of Anatomy and Neurobiology, School of Medicine, University of California, Irvine, CA 92697, USA
1 shared publication Jasmine Chavez
Department of Anatomy and Neurobiology, School of Medicine, University of California, Irvine, CA 92697, USA
1 shared publication
Latest Publications
- 27 November 2025
- Published by SAGE Publications in Shoulder & Elbow
- Vol. 18 (5) , 1040-1048
Liver dysfunction is associated with early postoperative complications following revision total shoulder arthroplasty
Background: This study investigates the association between the Aspartate Aminotransferase-to-Platelet Ratio Index (APRI), a simple and accessible measure of liver dysfunction, and 30-day postoperative complications following revision total shoulder arthroplasty (TSA). Methods: The ACS-NSQIP database was queried for all patients who underwent revision TSA between 2015 and 2022, identifying 2619 cases, of which 954 met inclusion criteria. Early postoperative complications, occurring within 30 days of surgery, were recorded. The study population was divided into three groups based on preoperative APRI: normal/reference (APRI ≤ 0.5), fibrosis (0.5 ≤ APRI < 1), and cirrhosis (APRI ≥ 1). Logistic regression analysis was conducted to investigate the association between preoperative APRI and postoperative complications. Results: Compared to normal liver function, fibrosis was independently associated with a greater likelihood of non-home discharge (odds ratio [OR] 2.28, 95% confidence interval [CI] 1.04-5.00; P = .039). Compared to normal liver function, cirrhosis was independently associated with a greater likelihood of experiencing pneumonia (OR 51.70, 95% CI 2.82-948.46; P = 0.008), blood transfusions (OR 4.52, 95% CI 1.26-16.19; P = 0.020), and deep vein thrombosis (OR 23.91, 95% CI 1.93-296.27; P = 0.013). Discussion: Fibrosis and cirrhosis based on APRI are predictors of early complications following revision TSA. Level of Evidence: Level III; Retrospective Cohort Comparison; Prognosis Study
- 27 November 2025
- Published by SAGE Publications in Shoulder & Elbow
- Vol. 18 (5) , 1040-1048
Liver dysfunction is associated with early postoperative complications following revision total shoulder arthroplasty
Background: This study investigates the association between the Aspartate Aminotransferase-to-Platelet Ratio Index (APRI), a simple and accessible measure of liver dysfunction, and 30-day postoperative complications following revision total shoulder arthroplasty (TSA). Methods: The ACS-NSQIP database was queried for all patients who underwent revision TSA between 2015 and 2022, identifying 2619 cases, of which 954 met inclusion criteria. Early postoperative complications, occurring within 30 days of surgery, were recorded. The study population was divided into three groups based on preoperative APRI: normal/reference (APRI ≤ 0.5), fibrosis (0.5 ≤ APRI < 1), and cirrhosis (APRI ≥ 1). Logistic regression analysis was conducted to investigate the association between preoperative APRI and postoperative complications. Results: Compared to normal liver function, fibrosis was independently associated with a greater likelihood of non-home discharge (odds ratio [OR] 2.28, 95% confidence interval [CI] 1.04-5.00; P = .039). Compared to normal liver function, cirrhosis was independently associated with a greater likelihood of experiencing pneumonia (OR 51.70, 95% CI 2.82-948.46; P = 0.008), blood transfusions (OR 4.52, 95% CI 1.26-16.19; P = 0.020), and deep vein thrombosis (OR 23.91, 95% CI 1.93-296.27; P = 0.013). Discussion: Fibrosis and cirrhosis based on APRI are predictors of early complications following revision TSA. Level of Evidence: Level III; Retrospective Cohort Comparison; Prognosis Study
- Open Access
- 18 August 2021
- Published by Elsevier in STAR Protocols
- Vol. 2 (3) , 100759
Protocol for remapping of place cells in disease mouse models
- 18 August 2021
- Published by Elsevier in STAR Protocols
- Vol. 2 (3) , 100759
Open AccessProtocol for remapping of place cells in disease mouse models